| 2013 | Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool | ANNALS OF SURGICAL ONCOLOGY |
| 2012 | Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience.
| BMC CANCER |
| 2023 | Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2010 | Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. | ONCOLOGY REPORTS |
| 2009 | Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
| ANNALS OF ONCOLOGY |
| 2022 | Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study | CLINICAL CANCER RESEARCH |
| 2020 | Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study | LANCET ONCOLOGY |
| 2005 | Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells | INTERNATIONAL JOURNAL OF CANCER |
| 2019 | Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2019 | Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
| Cancer Research and Treatment |
| 2009 | Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction
| YONSEI MEDICAL JOURNAL |
| 2007 | Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2021 | Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia | TARGETED ONCOLOGY |
| 2002 | Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2011 | Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial. | BREAST CANCER |
| 2012 | Body image, sexual function and depression in Korean patients with breast cancer: modification by 5-HTT polymorphism | SUPPORTIVE CARE IN CANCER |
| 2023 | Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination | JOURNAL OF GASTRIC CANCER |
| 2013 | Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial | LANCET ONCOLOGY |
| 2008 | Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2017 | Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
| ONCOTARGET |
| 2018 | Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer | ANTICANCER RESEARCH |
| 2011 | CD44-SLC1A2 gene fusions in gastric cancer.
| SCIENCE TRANSLATIONAL MEDICINE |
| 2003 | cDNA Microarray Experiment: Design Issues in Early Stage and the Need of Normalization
| CANCER RESEARCH AND TREATMENT |
| 2007 | Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy | ACTA ONCOLOGICA |
| 2020 | Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study | SUPPORTIVE CARE IN CANCER |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| ONCOLOGY LETTERS |
| 2002 | Changes of telomerase activity and proliferation by inhibition of reverse transcriptase activity in human cancer cell.
| CANCER RESEARCH AND TREATMENT |
| 2009 | Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. | ONCOLOGY RESEARCH |
| 1999 | Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast | International Journal of Oncology |
| 2007 | Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute | ANNALS OF SURGICAL ONCOLOGY |
| 2013 | Changing treatment patterns in elderly patients with resectable colon cancer | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 1994 | Changing trends in histologic types of lung cancer during the last decade(1981-1990) in Korean Hospital-based study | LUNG CANCER |
| 2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | CANCER SCIENCE |
| 2008 | Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
| BMC CANCER |
| 2020 | Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
| MOLECULAR THERAPY-ONCOLYTICS |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
| 2016 | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
| CANCER RESEARCH AND TREATMENT |
| 2013 | Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent | INVESTIGATIONAL NEW DRUGS |
| 2011 | Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2010 | Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites
| CANCER RESEARCH AND TREATMENT |
| 2015 | Clinicopathological features and prognostic significance of HER2 expression in gastric cancer | ONCOLOGY |
| 2013 | Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. | ANTICANCER RESEARCH |
| 2014 | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial | INVESTIGATIONAL NEW DRUGS |
| 1999 | Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma | ONCOLOGY REPORTS |
| 2021 | Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis | EUROPEAN JOURNAL OF CANCER |
| 1997 | Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate | CANCER LETTERS |
| 2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| ONCOTARGET |
| 2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
| ONCOTARGET |
| 2019 | Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
| Journal for Immunotherapy of Cancer |
| 2004 | Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids | JOURNAL OF INORGANIC BIOCHEMISTRY |
| 2009 | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 1997 | Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma | CANCER |
| 2000 | Correlation of tissue and blood plasminogen activation system in breast cancer | Journal of Neurology, Neurosurgery and Psychiatry |
| 2009 | Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC). | BREAST CANCER RESEARCH AND TREATMENT |
| 2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | ANNALS OF SURGERY |
| 2005 | Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss | BREAST CANCER RESEARCH AND TREATMENT |
| 2008 | Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer | ARCHIVES OF SURGERY |
| 2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| ONCOTARGET |
| 2021 | Detection of asymptomatic recurrence improves survival of gastric cancer patients
| CANCER MEDICINE |
| 2005 | Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray
| CLINICAL CANCER RESEARCH |
